News

Recent Articles

2018 CIRN Trainee Scholarship – Applications Due June 15, 2018

On behalf of the CIRN Training and Education Committee, we are pleased to announce that the 2018 Trainee Scholarship competition is open. Applications for graduate studentships and postdoctoral fellowships will be accepted until June 15. Eligibility requirements and application details can be found at www.cirnetwork.ca/trainee. If you have any questions, please contact, jason.bremner@iwk.nshealth.ca.  

Posted on May 1, 2018

UBC Vaccinology Research Symposium, November 2015

The Division of Infectious Diseases  is very pleased to be collaborating with the UBC Department of Pediatrics, the Vaccine Evaluation Center, CAIRE and CFRI  to host a Vaccinology Research Symposium on November 5th and 6th.  This Symposium or Festschrift is in celebration of the more than 38 years that Dr. David Scheifele has dedicated to… Read More»

Posted on August 18, 2015

2016 Weaver Tremblay Award Winner Dr. Janice Graham

Congratulations to Dr. Janice Graham, who has been chosen for the Weaver-Tremblay Award in Canadian Applied Anthropology in 2016. The Weaver-Tremblay Award is the top honour for Anthropology in Canada. Dr. Graham  is the Associate Director of Health Policy and Translation with the Canadian Center for Vaccinology, and an investigator for CIRN’s Social Sciences and Humanities Network. 

Posted on July 29, 2015

CIRN/CCfV Research Education Series 2015 Fall/Winter Schedule

This series, jointly organized by the Canadian Immunization Research Network (CIRN) and the Canadian Center for Vaccinology (CCfV), includes one or two presentations and intermittently a CIRN Curriculum Case Study each month, available by webinar.

Posted on July 22, 2015

Immunovaccine Initiates Clinical Trial with DPX-RSV Vaccine

Halifax, Nova Scotia; June 30, 2015 – Immunovaccine Inc. , a clinical stage vaccine and immunotherapy company, today announced that it has enrolled the first healthy adult volunteer in a Phase 1 clinical study of its respiratory syncytial virus (RSV) vaccine. The Phase 1 study will evaluate the safety and immune response profile of the… Read More»

Posted on July 9, 2015
Newer»